Exide Industries - Stock Note - 030723
Exide Industries - Stock Note - 030723
Exide Industries - Stock Note - 030723
Stock Note
Exide Industries Ltd.
1
Exide Industries Ltd.
Industry LTP Recommendation Base Case Fair Value Bull Case Fair Value Time Horizon
Auto Ancillaries Rs 237 Buy in Rs 235-241 band & add more on dips in Rs 209-213 band Rs 263 Rs 285 3-4 quarters
Our Take:
HDFC Scrip Code EXIINDEQNR
Exide Industries (Exide) is the leading battery manufacturer in India catering to automobiles and industrial segments. The company is present
BSE Code 500086
in the OEM as well as replacement and export segments. Exide is the market leader in the organized lead acid battery segment, commanding
NSE Code EXIDEIND
the majority market share in the domestic market. In organized OEM segment, its overall market share 3/4W is ~60% while 2W it is ~75%.
Bloomberg EXID IN
CMP Jun 30, 2023 236.7 Over the last 3 years the company has almost doubled its distributor network and entered new geographies in Europe and Russia. In the
Equity Capital (Rs cr) 85.0 domestic market, organised players are expected to continue gaining market share in the auto replacement segment due to GST and stricter
Face Value (Rs) 1 environmental norms.
Equity Share O/S (cr) 85.0
Market Cap (Rs cr) 20124 The company has collaborated with Svolt, China to set up lithium-ion battery manufacturing plant in India. SVOLT partnership would support
Book Value (Rs) 131.9 manufacturing/technology/raw material procurement. It has already incurred capex of Rs 715cr and expects total capex of Rs 4000cr in the
Avg. 52 Wk Volumes 31,07,000 first phase by FY25. With increasing EV penetration, the company would have first mover advantage as the homologation process with OEM
52 Week High (Rs) 238.7 takes 1.5-2 years.
52 Week Low (Rs) 136.8
Valuation & Recommendation:
Share holding Pattern % (Mar, 2023) The management expects replacement demand to pick up in FY24. Its battery management system subsidiary has an outstanding orderbook
Promoters 46.0 of Rs 600-700cr and expects revenue of Rs 400-500cr in FY24. Focus on premium products and calibrated price hike should aid in margin
Institutions 31.2 expansion. The high capex lithium ion battery business could provide trigger for the medium term although it carries risk of execution and
Non Institutions 22.8 technology changes.
Total 100.0
We expect Exide’s Revenue/PAT to grow at 12/19% CAGR over FY23-FY25E. We believe investors can buy the stock in Rs 235-241 band and
add on dips in Rs 209-213 band (14x FY25E EPS) for a base case fair value of Rs 263 (17.5x FY25E EPS) and bull case fair value of Rs 285 (19x
FY25E EPS) over the next 3-4 quarters. We are not separately ascribing any value to the 8.7 cr shares of HDFC life held by Exide for valuation
purposes.
2
Exide Industries Ltd.
Financial Summary
Particulars (Rs cr) Q4FY23 Q4FY22 YoY (%) Q3FY23 QoQ (%) FY22 FY23 FY24E FY25E
Operating Income 3,543 3,417 3.7 3,412 3.8 12,382 14,592 16,285 18,369
EBITDA 367 350 4.9 401 -8.4 1,396 1,568 1,799 2,076
APAT 208 4,120 -95.0 223 -6.9 4,684 904 1,056 1,277
Diluted EPS (Rs) 2.4 48.5 -95.0 2.6 -6.9 55.1 10.6 12.4 15.0
RoE (%) 53.5 8.3 9.1 10.2
P/E (x) 4.3 22.3 19.1 15.8
EV/EBITDA (x) 13.8 12.4 11.2 10.0
(Source: Company, HDFC sec)
Gross margin expanded 180bp YoY (-250bp QoQ) to 29.8%. However, operating deleverage restricted EBITDA margin expansion to just 10bp
YoY (-140bp QoQ) to 10.4%. Adj PAT declined 25% YoY to Rs 208cr.
Key Triggers
Automotive replacement and industrial segment to drive steady sales
As the automobile battery’s life is about 3-3.5 years, it translates into linear replacement demand from the existing vehicle population. The
automotive replacement battery segment will continue to offer a secular and profitable growth opportunity, driven by (a) increasing
penetration of automobiles driving expansion in automobile population, (b) GST-led consolidation and (c) New segment like E-Rickshaws. GST
and new segments would drive consolidation in the replacement market of automotive and inverter batteries, leading to strong growth for
the organised players.
New segments in industrial batteries – motive power, and solar applications – would drive growth, as conventional drivers of this segment
stabilise. Electric vehicles (EVs) are unlikely to displace lead-acid batteries (LAB) in the medium term as the cost of lithium-ion batteries is still
very high, and LAB are still preferred for SLI (starter, lighting, and ignition) applications.
3
Exide Industries Ltd.
Foray into lithium ion cell manufacturing
With an eye on the future, Exide has laid out a detailed roadmap for its Lithium-ion cell manufacturing facility. It is looking to incur a capex of
Rs 4,000 crore for the first phase of the 6 GWh Lithium-ion cell plant at Bengaluru. The work on the facility has already started and the project
is progressing extremely well. All necessary permissions have been secured and site-enabling work has been completed. The first phase of
the said plant will begin by the second half of the financial year 2025, and the management expects the production to stabilise by the financial
year 2026.
Exide will also spend another Rs 2,000 crore for the second phase of this plant. The management also mentioned that it has reached out to
several OEMs with regard to its lithium-ion plants and that they have received strong interest from its legacy automotive customers.
Exide has a tie-up with SVOLT, China to provide the technology for Li-ion battery manufacturing and can ride piggy back on its supply chain.
As part of the deal, SVOLT will grant Exide an irrevocable right and license to use, exploit, and commercialize applicable lithium-ion cell
manufacturing technology and know-how in India. SVOLT will also provide full support for the establishment of a state-of-the-art greenfield
manufacturing facility.
Svolt is amongst the biggest battery manufacturers and its scale would ensure lower material prices for Exide. As a global high-tech company
and spin-off of the Chinese automobile manufacturer Great Wall Motors, SVOLT develops and produces lithium-ion batteries and battery
systems for electric vehicles as well as energy storage.
Before 2018, SVOLT was only an unknown player, but in just four years, it has advanced to become one of the top 10 ten in the world.
According to SNE Research, a Korean market research institution, the cumulative installed capacity of SVOLT reached 2.6 GWh in the first half
of 2022, an increase of 160% year-on-year, ranking it among the top 10 globally.
SVOLT has established many production and research bases in China. It has also announced six production expansion plans in 2022, involving
182.6 GWh battery capacity, with a total investment of 67.6 billion yuan. The company is in the process of building R&D bases in Europe,
South Korea and other locales to construct a global R&D, production and service network.
4
Exide Industries Ltd.
Lithium-ion demand (GWh) in India by 2030
5
Exide Industries Ltd.
Declining share of unorganized segment
The share of the unorganised segment in the replacement market has been gradually declining but is still 30-40%. Organised players dominate
the PV and 2W segments, with a 70-80% share. The share of unorganised/small organized players in the CV, tractors, and home inverter
segments is higher at 50-60%. However, going forward, it is expected that the organized market will consolidate through the acquisition of
small players by larger ones. In addition, unorganized players are more likely to wind down due to stringent rules on recycling and
manufacturing processes.
To counter the unorganised segment, the organised players are increasingly promoting entry-level brands at competitive pricing and shorter
warranty period and are expanding distribution network in the semi-urban and rural markets. This should facilitate in increasing their share
in the overall battery market.
Strong financial risk profile, with negligible debt and healthy cash accruals
Exide has remained net debt negative for the last several years, aided by healthy accruals. At the consolidated level, the company’s total net
cash accruals for the period FY19-FY22 stood at over Rs 4,000cr net cash accruals, and it had sizeable cash and liquid investments of Rs 911cr
as against a consolidated gross debt of Rs 532cr (including lease liabilities of Rs 310cr) as on March 31, 2022. The net debt negative position
6
Exide Industries Ltd.
has resulted in strong capital structure and coverage metrics for EIL. Exide also has long-term investments in HDFC Life Insurance Company
Limited (8.7 cr shares), fair value of which is more than Rs 5600cr
Forex volatility
Adverse currency movement may remain a risk to its profitability given that the key raw material - lead prices are based on international
prices and Exide exports ~10% of its sales.
7
Exide Industries Ltd.
Exide faces the risk of execution in the large Lithium ion project:
Exide has collaborated with Svolt, China to set up lithium-ion battery manufacturing plant in India. Svolt partnership would support
manufacturing/technology/raw material procurement. It has already incurred capex of Rs 715cr and expects total capex of Rs 4000cr
in the first phase by FY25. In case this project faces execution/teething delays, then it may postpone the upside in revenues and profits
affecting return ratios in the interim. The project being in the initial stages of construction exposes it to time and cost overruns.
Further, significant dependence on imports for sourcing raw materials exposes it to geopolitical and region-specific risks for raw
materials. Also, there are risks on the off-take front, given that EV penetration is still in nascent stages and the company does not have
any ‘take-or-pay’ agreements. Also in case of technology changes in the interim, affecting the anticipated scale of demand for lithium
ion, then the economic viability of the project may come under cloud. However while the capex is significant, it is critical to capitalise
on opportunities from EVs.
8
Exide Industries Ltd.
Company Background:
For more than seven decades, Exide Industries has been one of India’s most reliable brands, enjoying unrivalled reputation and recall. A
leader in packaged power technology, Exide is India’s largest storage battery company with the widest range of both conventional flooded
as well as latest VRLA batteries. Constant emphasis on innovation, extensive geographic footprint, strong relationship with marquee clients
and steady technology upgrades with global business partners have made the company a frontrunner in the lead-acid storage batteries space
for both automotive and industrial applications. Exide designs, manufactures, markets and sells the widest range of lead acid storage
batteries in the world to cover the broadest spectrum of applications.
It is constantly upgrading its technology and also acquiring new technology to meet the ever increasing demands of its customers. In addition
to in-house R&D Centre recognised by the Government of India's Department of Scientific and Industrial Research (DSIR), Exide also acquires
new technology through technical collaboration agreements with leading international battery manufacturers. Out of the nine factories,
seven factories are dedicated to manufacturing batteries and the other two for home UPS Systems. Company manufactures batteries for
automotive, power, renewable energy, telecom, infrastructure projects, as well as the railways, mining and defence sectors and also solar
projects and submarines. Company derives about 30% of its revenues from automotive segment while around 70% revenues from industrial
battery segment. Exide derived ~10% of its revenues from exports and targets to double the size by FY25.
Exide also had a presence in the Life Insurance business through its fully-owned subsidiary, namely Exide Life insurance, which was sold to
HDFC Life Insurance in Q3FY22 for a consideration of Rs 726cr cash and 8.7cr shares of HDFC Life Insurance.
Peer Comparison
Sales EBITDA Margin (%) PAT RoE (%) P/E (x) P/B (x)
(Rs cr) Mcap
FY23 FY24E FY25E FY23 FY24E FY25E FY23 FY24E FY25E FY23 FY24E FY25E FY23 FY24E FY25E FY23 FY24E FY25E
Exide Ind 20124 14592 16285 18369 10.7 11.1 11.3 904 1056 1277 8.3 9.1 10.2 22.3 19.1 15.8 1.8 1.7 1.5
Amara Raja Batt 11638 10388 11660 12599 13.0 13.9 13.9 728 850 954 14.1 16.0 15.4 16.0 13.6 12.5 2.2 2.0 1.8
(Source: HDFC sec, Bloomberg)
9
Exide Industries Ltd.
Financials
Income Statement Balance Sheet
(Rs cr) FY21 FY22 FY23 FY24E FY25E (Rs cr) FY21 FY22 FY23 FY24E FY25E
Net Revenues 10041 12382 14592 16285 18369 SOURCE OF FUNDS
Growth (%) 1.9 23.3 17.9 11.6 12.8 Share Capital 85 85 85 85 85
Operating Expenses 8685 10986 13024 14485 16293 Reserves 6809 10521 11125 11970 12991
EBITDA 1356 1396 1568 1799 2076 Shareholders' Funds 6894 10606 11210 12055 13076
Growth (%) -0.7 3.0 12.4 14.8 15.4 Total Debt 0 0 0 725 1225
EBITDA Margin (%) 13.5 11.3 10.7 11.1 11.3 Net Deferred Taxes 77 -58 -116 -116 -116
Depreciation 379 413 456 478 471 Other Non-curr. Liab. 290 284 284 326 367
Other Income 65 80 132 122 138 Total Sources of Funds 7260 10831 11378 12989 14553
EBIT 1042 1063 1245 1444 1742 APPLICATION OF FUNDS
Interest expenses 24 38 30 32 35 Net Block & Goodwill 2672 2802 2850 2524 2002
PBT 1018 5719 1215 1412 1707 CWIP 201 312 101 1250 2400
Tax 260 1035 311 356 430 Investments 3244 6151 6452 6472 6488
PAT 758 4684 904 1056 1277 Other Non-Curr. Assets 185 108 110 130 147
Share of Asso./Minority Int. 0 0 0 0 0 Total Non Current Assets 6116 9265 9403 10245 10891
Adj. PAT 758 4684 904 1056 1277 Inventories 2346 2458 2989 3458 3770
Growth (%) -8.1 517.7 -80.7 16.9 20.9 Debtors 887 1192 1274 1477 1680
EPS 8.9 55.1 10.6 12.4 15.0 Cash & Equivalents 91 161 74 71 60
Other Current Assets 187 208 194 170 196
Total Current Assets 3512 4020 4532 5175 5705
Creditors 1642 1610 1526 1785 1912
Other Current Liab & Provisions 727 844 1031 1147 1281
Total Current Liabilities 2369 2454 2557 2931 3194
Net Current Assets 1144 1566 1975 2244 2512
Total Application of Funds 7260 10831 11378 12989 14553
10
Exide Industries Ltd.
Cash Flow Statement Key Ratios
(Rs cr) FY21 FY22 FY23 FY24E FY25E Particulars FY21 FY22 FY23 FY24E FY25E
Reported PBT 1018 5719 1215 1412 1707 Profitability Ratios (%)
Non-operating & EO items -39 -4750 -77 22 25 EBITDA Margin 13.5 11.3 10.7 11.1 11.3
Interest Expenses 23 31 30 32 35 EBIT Margin 10.4 8.6 8.5 8.9 9.5
Depreciation 379 413 456 478 471 APAT Margin 7.6 37.8 6.2 6.5 7.0
Working Capital Change 304 -353 -454 -273 -279 RoE 11.5 53.5 8.3 9.1 10.2
Tax Paid -272 -1048 -321 -356 -430 RoCE 15.8 12.2 11.4 12.0 12.9
OPERATING CASH FLOW ( a ) 1413 12 848 1315 1529 Solvency Ratio (x)
Capex -338 -581 -321 -1300 -1100 Net Debt/EBITDA -0.1 -0.1 0.0 0.4 0.6
Free Cash Flow 1075 -569 527 15 429 Net D/E 0.0 0.0 0.0 0.1 0.1
Investments -872 218 197 0 0 PER SHARE DATA (Rs)
Non-operating income -66 636 -763 -500 -650 EPS 8.9 55.1 10.6 12.4 15.0
INVESTING CASH FLOW ( b ) -1277 273 -888 -1800 -1750 CEPS 13.4 60.0 16.0 18.0 20.6
Debt Issuance / (Repaid) 0 0 -10 725 500 BV 81.1 124.8 131.9 141.8 153.8
Interest Expenses -4 -14 -6 -32 -35 Dividend 2.0 2.0 2.0 2.4 3.0
FCFE 132 271 -55 207 244 Turnover Ratios (days)
Share Capital Issuance 0 0 0 0 0 Debtor days 31 31 31 31 31
Dividend -170 -170 0 -211 -255 Inventory days 82 71 68 72 72
Others -24 -30 -31 0 0 Creditors days 49 48 39 37 37
FINANCING CASH FLOW ( c ) -174 -184 -16 482 210 VALUATION (x)
NET CASH FLOW (a+b+c) -38 101 -55 -4 -11 P/E 26.5 4.3 22.3 19.1 15.8
P/BV 2.9 1.9 1.8 1.7 1.5
EV/EBITDA 14.1 13.8 12.4 11.2 10.0
EV / Revenues 1.9 1.6 1.3 1.2 1.1
Dividend Yield (%) 0.8 0.8 0.8 1.0 1.3
Dividend Payout (%) 22.4 3.6 18.8 19.3 20.0
(Source: Company, HDFC sec)
11
Exide Industries Ltd.
Price chart
12
Exide Industries Ltd.
Disclosure:
I, Atul Karwa, Reesearch Analyst, MMS, authors and the names subscribed to this report, hereby certify that all of the views expressed in this research report accurately reflect our views about the subject issuer(s) or securities. SEBI conducted the inspection and based on their observations have issued
advise/warning. The said observations have been complied with. We also certify that no part of our compensation was, is, or will be directly or indirectly related to the specific recommendation(s) or view(s) in this report.
Research Analyst or his/her relative or HDFC Securities Ltd. does not have any financial interest in the subject company. Also Research Analyst or his relative or HDFC Securities Ltd. or its Associate may have beneficial ownership of 1% or more in the subject company at the end of the month immediately
preceding the date of publication of the Research Report. Further Research Analyst or his relative or HDFC Securities Ltd. or its associate does not have any material conflict of interest.
Any holding in stock – No
HDFC Securities Limited (HSL) is a SEBI Registered Research Analyst having registration no. INH000002475.
Disclaimer:
This report has been prepared by HDFC Securities Ltd and is solely for information of the recipient only. The report must not be used as a singular basis of any investment decision. The views herein are of a general nature and do not consider the risk appetite or the particular circumstances of an individual
investor; readers are requested to take professional advice before investing. Nothing in this document should be construed as investment advice. Each recipient of this document should make such investigations as they deem necessary to arrive at an independent evaluation of an investment in securities
of the companies referred to in this document (including merits and risks) and should consult their own advisors to determine merits and risks of such investment. The information and opinions contained herein have been compiled or arrived at, based upon information obtained in good faith from
sources believed to be reliable. Such information has not been independently verified and no guaranty, representation of warranty, express or implied, is made as to its accuracy, completeness or correctness. All such information and opinions are subject to change without notice. Descriptions of any
company or companies or their securities mentioned herein are not intended to be complete. HSL is not obliged to update this report for such changes. HSL has the right to make changes and modifications at any time.
This report is not directed to, or intended for display, downloading, printing, reproducing or for distribution to or use by, any person or entity who is a citizen or resident or located in any locality, state, country or other jurisdiction where such distribution, publication, reproduction, availability or use
would be contrary to law or regulation or what would subject HSL or its affiliates to any registration or licensing requirement within such jurisdiction.
If this report is inadvertently sent or has reached any person in such country, especially, United States of America, the same should be ignored and brought to the attention of the sender. This document may not be reproduced, distributed or published in whole or in part, directly or indirectly, for any
purposes or in any manner.
Foreign currencies denominated securities, wherever mentioned, are subject to exchange rate fluctuations, which could have an adverse effect on their value or price, or the income derived from them. In addition, investors in securities such as ADRs, the values of which are influenced by foreign
currencies effectively assume currency risk. It should not be considered to be taken as an offer to sell or a solicitation to buy any security.
This document is not, and should not, be construed as an offer or solicitation of an offer, to buy or sell any securities or other financial instruments. This report should not be construed as an invitation or solicitation to do business with HSL. HSL may from time to time solicit from, or perform broking, or
other services for, any company mentioned in this mail and/or its attachments.
HSL and its affiliated company(ies), their directors and employees may; (a) from time to time, have a long or short position in, and buy or sell the securities of the company(ies) mentioned herein or (b) be engaged in any other transaction involving such securities and earn brokerage or other compensation
or act as a market maker in the financial instruments of the company(ies) discussed herein or act as an advisor or lender/borrower to such company(ies) or may have any other potential conflict of interests with respect to any recommendation and other related information and opinions.
HSL, its directors, analysts or employees do not take any responsibility, financial or otherwise, of the losses or the damages sustained due to the investments made or any action taken on basis of this report, including but not restricted to, fluctuation in the prices of shares and bonds, changes in the
currency rates, diminution in the NAVs, reduction in the dividend or income, etc.
HSL and other group companies, its directors, associates, employees may have various positions in any of the stocks, securities and financial instruments dealt in the report, or may make sell or purchase or other deals in these securities from time to time or may deal in other securities of the companies
/ organizations described in this report. As regards the associates of HSL please refer the website.
HSL or its associates might have managed or co-managed public offering of securities for the subject company or might have been mandated by the subject company for any other assignment in the past twelve months.
HSL or its associates might have received any compensation from the companies mentioned in the report during the period preceding twelve months from t date of this report for services in respect of managing or co-managing public offerings, corporate finance, investment banking or merchant banking,
brokerage services or other advisory service in a merger or specific transaction in the normal course of business.
HSL or its analysts did not receive any compensation or other benefits from the companies mentioned in the report or third party in connection with preparation of the research report. Accordingly, neither HSL nor Research Analysts have any material conflict of interest at the time of publication of this
report. Compensation of our Research Analysts is not based on any specific merchant banking, investment banking or brokerage service transactions. HSL may have issued other reports that are inconsistent with and reach different conclusion from the information presented in this report.
Research entity has not been engaged in market making activity for the subject company. Research analyst has not served as an officer, director or employee of the subject company. We have not received any compensation/benefits from the subject company or third party in connection with the
Research Report.
HDFC securities Limited, I Think Techno Campus, Building - B, "Alpha", Office Floor 8, Near Kanjurmarg Station, Opp. Crompton Greaves, Kanjurmarg (East), Mumbai 400 042 Phone: (022) 3075 3400 Fax: (022) 2496 5066
Compliance Officer: Murli V Karkera Email: [email protected] Phone: (022) 3045 3600
For grievance redressal contact Customer Care Team Email: [email protected] Phone: (022) 3901 9400
HDFC Securities Limited, SEBI Reg. No.: NSE, BSE, MSEI, MCX: INZ000186937; AMFI Reg. No. ARN: 13549; PFRDA Reg. No. POP: 11092018; IRDA Corporate Agent License No.: CA0062; SEBI Research Analyst Reg. No.: INH000002475; SEBI Investment Adviser Reg. No.: INA000011538; CIN -
U67120MH2000PLC152193
Investment in securities market are subject to market risks. Read all the related documents carefully before investing.
Mutual Funds Investments are subject to market risk. Please read the offer and scheme related documents carefully before investing.
Registration granted by SEBI, membership of BASL (in case of IAs) and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors.
13